Published in Neurol Sci on July 26, 2015
Moving Forward by Stimulating the Brain: Transcranial Direct Current Stimulation in Post-Stroke Hemiparesis. Front Hum Neurosci (2016) 0.83
Effect of high-frequency repetitive transcranial magnetic stimulation on major depressive disorder in patients with Parkinson's disease. J Neurol (2016) 0.77
The Network Model of Depression as a Basis for New Therapeutic Strategies for Treating Major Depressive Disorder in Parkinson's Disease. Front Hum Neurosci (2016) 0.75
Meta-Analysis of the Relationship between Deep Brain Stimulation in Patients with Parkinson's Disease and Performance in Evaluation Tests for Executive Brain Functions. Parkinsons Dis (2017) 0.75
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry (2007) 5.59
What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry (2000) 4.66
Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain (1994) 3.57
Meta-analysis: recent developments in quantitative methods for literature reviews. Annu Rev Psychol (2001) 3.45
GRADE guidelines: 5. Rating the quality of evidence--publication bias. J Clin Epidemiol (2011) 3.44
Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet (1996) 3.33
A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord (2008) 2.81
Preconditioning of low-frequency repetitive transcranial magnetic stimulation with transcranial direct current stimulation: evidence for homeostatic plasticity in the human motor cortex. J Neurosci (2004) 2.68
Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry (1999) 2.55
The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study. PLoS One (2011) 2.02
Is there a future for therapeutic use of transcranial magnetic stimulation? Nat Rev Neurosci (2007) 2.00
Meta-analysis of data from animal studies: a practical guide. J Neurosci Methods (2013) 1.96
Major depressive disorder in Parkinson's disease: a register-based study. Acta Psychiatr Scand (2002) 1.64
The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study. Mov Disord (2010) 1.64
Regional brain function, emotion and disorders of emotion. Curr Opin Neurobiol (1999) 1.32
Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study. Eur J Neurol (2003) 1.28
Effect of transcranial magnetic stimulation on Parkinson motor function--systematic review of controlled clinical trials. Mov Disord (2009) 1.20
Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology (2002) 1.18
Use and safety of a new repetitive transcranial magnetic stimulator. Electroencephalogr Clin Neurophysiol (1996) 1.10
Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 1.10
Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. BMC Neurol (2010) 1.00
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression. Mov Disord (2005) 0.95
A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group. Int Psychogeriatr (1995) 0.94
Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis. Ann Pharmacother (2006) 0.91
rTMS treatment for depression in Parkinson's disease increases BOLD responses in the left prefrontal cortex. Int J Neuropsychopharmacol (2007) 0.90
Repetitive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo. Eur J Neurosci (1999) 0.85
Repetitive transcranial magnetic stimulation as treatment for depression in Parkinson's disease. Mov Disord (2010) 0.82
Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression? CNS Drugs (2003) 0.76